Agricultural Marketing Company Limited (DSE:AMCL(PRAN))

Orchard Therapeutics Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	43.68	44.11	43.35	44.93	42.99	45.58
Depreciation & Amortization	29.86	28.06	18.65	37.44	44.57	54.79
Other Operating Activities	164.91	152.31	141.75	136.06	139.35	103.48
Change in Accounts Receivable	-117.39	42.81	112.84	-31.03	-33.93	-22.55
Change in Inventory	-92.4	-97.57	-110.01	-53.87	4.01	-9.62
Change in Accounts Payable	-22.68	-15.33	-2.02	-8.24	24.94	1.19
Change in Other Net Operating Assets	-87.96	-56.49	-9.14	31.33	-52.13	-48.69
Operating Cash Flow	-81.99	97.92	195.41	156.62	169.8	124.18
Operating Cash Flow Growth	-	-49.89%	24.77%	-7.76%	36.74%	-55.81%
Capital Expenditures	0	-134.97	-46.07	-1.09	-	-0.21
Other Investing Activities	0	36.67	-	-	0.38	-
Investing Cash Flow	0	-98.3	-46.07	-1.09	0.38	-0.21
Short-Term Debt Issued	-	83.14	-	28.95	-	54.99
Long-Term Debt Issued	-	91.76	-	-	-	-
Total Debt Issued	266.04	174.9	-	28.95	-	54.99
Short-Term Debt Repaid	-	-	-9.82	-	-56.37	-
Long-Term Debt Repaid	-	-2.75	-2.57	-3.05	-1.74	-48.39
Total Debt Repaid	-2.61	-2.75	-12.39	-3.05	-58.1	-48.39
Net Debt Issued (Repaid)	263.43	172.15	-12.39	25.9	-58.1	6.61
Common Dividends Paid	-25.14	-25.23	-25.21	-31.71	-24.97	-25.69
Other Financing Activities	-166.85	-150.53	-141.33	-137.13	-128.15	-126.64
Financing Cash Flow	71.44	-3.61	-178.93	-142.94	-211.23	-145.73
Foreign Exchange Rate Adjustments	1.16	1.04	0.36	0.28	0.41	0.12
Net Cash Flow	-9.39	-2.95	-29.22	12.88	-40.64	-21.64
Free Cash Flow	-81.99	-37.05	149.35	155.54	169.8	123.97
Free Cash Flow Growth	-	-	-3.98%	-8.40%	36.97%	-55.88%
Free Cash Flow Margin	-2.31%	-1.12%	4.63%	4.93%	5.76%	4.69%
Free Cash Flow Per Share	-10.25	-4.63	18.67	19.44	21.23	15.50
Cash Interest Paid	166.85	150.53	141.33	137.13	128.15	126.71
Cash Income Tax Paid	76.46	57.73	45.01	40.36	37.27	65.92
Levered Free Cash Flow	-199.2	-137.27	2.22	37.53	54.56	0.12
Unlevered Free Cash Flow	-94.66	-42.88	90.87	124.48	137.2	78.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.